AesMed Introduces Blog Series on Korean Cytokines Mesotherapy for Hair Regrowth

AesMed is pleased to introduce a new three-part blog series exploring Korean cytokines mesotherapy for hair regrowth, with a special focus on AGF39™ and the clinical concept of CytoMesopecia.

As global interest in non-surgical hair regrowth solutions continues to grow, Korea has become one of the leading markets for advanced scalp care, dermatology-based hair treatments, and regenerative approaches to alopecia care. Through this blog series, AesMed shares key insights into how cytokines, growth factors, and professional scalp delivery methods can support a science-based approach to hair regrowth.

Part 1. What Is Korean Cytokines Mesotherapy for Hair Regrowth?
The first article introduces the concept of Korean cytokines mesotherapy and explains why cytokines are important in modern hair loss care.

Cytokines are signaling molecules that help cells communicate with each other. In hair biology, this communication plays an important role because the hair follicle is a highly dynamic structure that repeatedly moves through growth, regression, resting, and shedding phases.

Unlike simple scalp stimulation or general nutrient application, cytokines mesotherapy focuses on the biological environment of the scalp and hair follicles. The goal is to deliver carefully selected growth-related ingredients to the scalp area where follicle activity, hair cycle regulation, and cellular communication take place.

The article also introduces AesMed’s AGF39™, a Korean hair solution developed for professional clinical use and formulated with selected recombinant cytokine proteins.

Read Part 1:
https://aesmed.blog/what-is-korean-cytokines-mesotherapy-for-hair-regrowth-part-1/

Part 2. How AGF39™ Supports the Hair Follicle Environment
The second article takes a closer look at AGF39™ and how its formulation is designed to support the scalp and hair follicle environment.

Healthy hair growth depends on more than the visible hair shaft. The real biological activity takes place below the scalp surface, where the hair follicle interacts with surrounding cells, blood vessels, nutrients, and signaling molecules.

AGF39™ is formulated with seven recombinant cytokine proteins:
•    KGF
•    IGF-1
•    VEGF
•    bFGF
•    Noggin
•    FGF9
•    SOD

These ingredients are selected to support hair follicle activity, scalp condition, and the biological signals related to hair regrowth. The article also explains the importance of supporting dermal papilla activity, keratinocyte function, root sheath condition, scalp nutrition, oxidative stress protection, and anagen phase maintenance.

In addition to cytokines, AGF39™ also includes scalp-focused nutrients such as vitamin B complex, amino acids, minerals, ATP, coenzymes, retinol, and glutathione. This allows AGF39™ to be positioned not simply as a nutrient solution, but as a mechanism-based hair solution developed for professional clinical programs.

Read Part 2:
https://aesmed.blog/how-agf39-supports-the-hair-follicle-environment-part-2/

Part 3. From Diagnosis to Clinical Protocol: CytoMesopecia by AesMed
The final article focuses on the clinical application of CytoMesopecia, from diagnosis to treatment protocol and follow-up evaluation.

AesMed emphasizes that professional hair regrowth programs should begin with accurate diagnosis. Hair loss can have multiple causes, including androgenetic alopecia, alopecia areata, thyroid-related factors, inflammatory scalp conditions, nutritional imbalance, or other medical conditions.

The CytoMesopecia approach highlights the importance of evaluating scalp condition, hair loss progression, previous treatments, hair density, hair thickness, sebum balance, inflammation, and follicle condition before designing a treatment plan.

The article also explains professional delivery methods for AGF39™, including MTS, mesotherapy injection, and electroporation. These methods are intended to help selected active ingredients reach the scalp environment more effectively as part of a clinic-based hair regrowth program.

By combining AGF39™, professional diagnosis, standardized application, and follow-up evaluation, CytoMesopecia offers a structured approach to Korean cytokines mesotherapy for hair regrowth.

Read Part 3:
https://aesmed.blog/from-diagnosis-to-clinical-protocol-cytomesopecia-by-aesmed-part-3/

Advancing Science-Based Hair Regrowth Care
Through this three-part series, AesMed aims to provide clinics, distributors, and hair care professionals with a clearer understanding of Korean cytokines mesotherapy and its role in modern alopecia care.

AGF39™ reflects AesMed’s continued commitment to developing professional hair solutions based on follicle biology, scalp science, and clinical usability. With its focus on selected cytokines, scalp-focused nutrients, and professional treatment protocols, AGF39™ supports a differentiated approach to non-surgical hair regrowth care.

AesMed will continue to share educational content, clinical insights, and professional resources to support the global development of advanced hair and scalp care.